SCHEMBL20547288

SCHEMBL20547288

CCOC(=O)N1CCc2noc(-c3cccc(F)c3)c2CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
CYP3A4 P08684 1/20 0.50
GRM5 P41594 1/20 0.50
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
CASP1 P29466 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KCNH2 Q12809 1/20 0.42
KDM4E B2RXH2 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.39
GABRA5 P31644 2/20 0.39
OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547359 0.89 DPP4 (0.48) LMNACYP3A4GRM5RAB9ANPC1
SCHEMBL20547285 0.88 KCNH2 (0.56) LMNACYP3A4GRM5RAB9ANPC1
SCHEMBL20547217 0.87 LMNA (0.47) LMNACYP3A4RAB9ANPC1KMT2A
SCHEMBL20547218 0.87 KMT2A (0.51) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL20546709 0.82 LMNA (0.51) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL20547245 0.81 NPC1 (0.53) LMNACYP3A4RAB9ANPC1KMT2A
SCHEMBL20547362 0.81 SMN1; SMN2 (0.53) LMNACYP3A4RAB9ANPC1KMT2A
SCHEMBL20547293 0.78 NPC1 (0.54) LMNARAB9ANPC1KMT2AALDH1A1
SCHEMBL20547246 0.77 NPC1 (0.53) LMNARAB9ANPC1KMT2AMEN1
SCHEMBL22449890 0.74 SMN1; SMN2 (0.40) KMT2AMEN1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3560927-B1 AZEPINE DERIVATIVES ACTING AS 5-HT7 RECEPTOR MODULATORS KOREA INST SCI & TECH (KR) 2023-04-19 EP disclosed
EP-3560927-A1 AZEPINE DERIVATIVE ACTING AS 5-HT7 RECEPTOR MODULATOR Korea Institute of Science and Technology (KR) 2019-10-30 EP disclosed
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-10-08 US disclosed
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312509-A1 AZEPINE DERIVATIVES AS 5-HT7 RECEPTOR MODULATORS HTR7, HTR5A, HTR3A LMNA 2326/4885CYP3A4 800/4885GRM5 31/4885
US-10435408-B2 Azepine derivatives as 5-HT7 receptor modulators HTR7, HTR5A, HTR3A LMNA 2326/4885CYP3A4 800/4885GRM5 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.